These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29289367)

  • 1. Characterizing Predictors and Severity of Vasoplegia Syndrome After Heart Transplantation.
    Chan JL; Kobashigawa JA; Aintablian TL; Dimbil SJ; Perry PA; Patel JK; Kittleson MM; Czer LS; Zarrini P; Velleca A; Rush J; Arabia FA; Trento A; Esmailian F
    Ann Thorac Surg; 2018 Mar; 105(3):770-777. PubMed ID: 29289367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoplegia after heart transplantation: outcomes at 1 year.
    Chan JL; Kobashigawa JA; Aintablian TL; Li Y; Perry PA; Patel JK; Kittleson MM; Czer LS; Zarrini P; Velleca A; Rush J; Arabia FA; Trento A; Esmailian F
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):212-217. PubMed ID: 28459983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.
    Asleh R; Alnsasra H; Daly RC; Schettle SD; Briasoulis A; Taher R; Dunlay SM; Stulak JM; Behfar A; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Kushwaha SS
    J Am Heart Assoc; 2019 Nov; 8(22):e013108. PubMed ID: 31701791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes.
    Batchelor RJ; Wong N; Liu DH; Chua C; William J; Tee SL; Sata Y; Bergin P; Hare J; Leet A; Taylor AJ; Patel HC; Burrell A; McGiffin D; Kaye DM
    J Card Fail; 2022 Apr; 28(4):617-626. PubMed ID: 34974975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.
    Tecson KM; Lima B; Lee AY; Raza FS; Ching G; Lee CH; Felius J; Baxter RD; Still S; Collier JDG; Hall SA; Joseph SM
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era.
    Patarroyo M; Simbaqueba C; Shrestha K; Starling RC; Smedira N; Tang WH; Taylor DO
    J Heart Lung Transplant; 2012 Mar; 31(3):282-7. PubMed ID: 22112993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.
    Javorski MJ; Kerolos MM; Fareed J; Perez-Tamayo RA
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1322-1326. PubMed ID: 29730947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors.
    de Waal EEC; van Zaane B; van der Schoot MM; Huisman A; Ramjankhan F; van Klei WA; Marczin N
    BMC Anesthesiol; 2018 Dec; 18(1):185. PubMed ID: 30526494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation.
    Truby LK; Takeda K; Farr M; Beck J; Yuzefpolskaya M; Colombo PC; Topkara VK; Mancini D; Naka Y; Takayama H
    ASAIO J; 2018; 64(1):43-51. PubMed ID: 28777136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of Vasoplegia in the Absence of Primary Graft Dysfunction to Mortality Following Cardiac Transplantation.
    Raza FS; Lee AY; Jamil AK; Qin H; Felius J; Rafael AE; Gonzalez-Stawinski GV; Hall SA; Joseph SM; Lima B; Bindra AS
    Am J Cardiol; 2018 Dec; 122(11):1902-1908. PubMed ID: 30442225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation.
    Byrne JG; Leacche M; Paul S; Mihaljevic T; Rawn JD; Shernan SK; Mudge GH; Stevenson LW
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):327-32. PubMed ID: 15019656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance.
    Carrel T; Englberger L; Mohacsi P; Neidhart P; Schmidli J
    J Card Surg; 2000; 15(5):347-53. PubMed ID: 11599828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
    Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].
    Durán Bruce M; Gomar Sancho C; Holguera JC; Muliterno Español E
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):246-53. PubMed ID: 24507583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin concentrations.
    Wittwer ED; Lynch JJ; Oliver WC; Dearani JA; Burkhart HM; Mauermann WJ
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):625-30. PubMed ID: 24280713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment and outcomes of vasoplegia after cardiac surgery.
    Tsiouris A; Wilson L; Haddadin AS; Yun JJ; Mangi AA
    Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):557-565. PubMed ID: 28612323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment.
    Omar S; Zedan A; Nugent K
    Am J Med Sci; 2015 Jan; 349(1):80-8. PubMed ID: 25247756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.
    Squiers JJ; Saracino G; Chamogeorgakis T; MacHannaford JC; Rafael AE; Gonzalez-Stawinski GV; Hall SA; DiMaio JM; Lima B
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):263-270. PubMed ID: 28186268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with vasoplegic shock in the postoperative period of cardiac surgery and influence on morbidity and mortality of the use of arginine vasopressin as rescue therapy.
    Barrera Sánchez M; Royo Villa C; Ruiz de Gopegui Miguelena P; Gutiérrez Ibañes P; Carrillo López A
    Med Intensiva (Engl Ed); 2024 Jul; 48(7):392-402. PubMed ID: 38697904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoplegia in patients following ventricular assist device explant and heart transplantation.
    Emmanuel S; Pearman M; Jansz P; Hayward CS
    Perfusion; 2022 Mar; 37(2):152-161. PubMed ID: 33482711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.